alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2554 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2554

 To amend title I of the Omnibus Crime Control and Safe Streets Act of 
 1968 to extend the authorization of the Bulletproof Vest Partnership 
                Grant Program through fiscal year 2017.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

  Mr. Leahy (for himself, Mr. Schumer, Mr. Whitehouse, Mr. Coons, Ms. 
 Mikulski, Mr. Kohl, and Ms. Klobuchar) introduced the following bill; 
  which was read twice and referred to the Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
 To amend title I of the Omnibus Crime Control and Safe Streets Act of 
 1968 to extend the authorization of the Bulletproof Vest Partnership 
                Grant Program through fiscal year 2017.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Bulletproof Vest Partnership Grant 
Act of 2012''.

SEC. 2. REAUTHORIZATION.

    Section 1001(a)(23) of title I of the Omnibus Crime Control and 
Safe Streets Act of 1968 (42 U.S.C. 3793(a)(23)) is amended by striking 
``2012'' and inserting ``2017''.
                                 <all>
```
# Official Journal C 123/25 A

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 123 |
| | |
| English edition | Information and Notices | Volume 5725 April 2014 |

ISSN 1977-091X

Official Journal

of the European Union

C 123

English edition

Information and Notices

Volume 5725 April 2014

---

| Notice No | Contents | page |
| --- | --- | --- |
| | IV   Notices |
| | NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2014/C 123/01 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2014 to 31 March 2014(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council) | 1 |
| 2014/C 123/02 | Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2014 to 31 March 2014(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC) | 8 |

Notice No

Contents

page

IV   Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2014/C 123/01

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2014 to 31 March 2014(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

1

2014/C 123/02

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 March 2014 to 31 March 2014(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

(Decisions taken pursuant to Article 34 of Directive 2001/83/EC or Article 38 of Directive 2001/82/EC)

8

---

| EN | |
| --- | --- |

EN
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2440 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2440

     To renew the temporary suspension of duty on N-propyl gallate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             April 26, 2012

  Mr. Schumer introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
     To renew the temporary suspension of duty on N-propyl gallate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. N-PROPYL GALLATE.

    (a) In General.--Heading 9902.22.34 of the Harmonized Tariff 
Schedule of the United States (relating to benzoic acid, 3,4,5-
trihydroxy-, propyl ester) is amended by striking the date in the 
effective period column and inserting ``12/31/2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
STATE of Louisiana v. Octavia GARY

NO. 2017-K-0940

Supreme Court of Louisiana.

April 6, 2018

Denied.
**Exhibit
      32.1**





**Certification
      of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted
      pursuant to Section**


**906
      of the Sarbanes-Oxley Act of 2002**





In
      connection with the Annual Report of Avantair, Inc., a Delaware corporation
      (the
“Company”), on Form 10-K for the period ended June 30, 2008 as filed with
      the Securities and Exchange Commission on the date hereof (the “Report”), I,
      Steven Santo, Chief Executive Officer (principal executive officer) of the
      Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
      to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my
      knowledge:





(1)
      the
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934; and





(2)
      the
      information contained in the Report fairly presents, in all material respects,
      the financial condition and results of operations of the Company.





Date:
      September 24, 2008




/s/
                Steven SantoName:
            
            Steven
                SantoTitle:
            
            Chief
                Executive Officer
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains financial information extracted from the
unaudited condensed financial statements of T. Rowe Price Realty
Income Fund I, a No-Load Limited Partnership included in the
accompanying Form 10-Q for the period ended June 30, 1997 and is
qualified in its entirety by reference to such financial
statements.
</LEGEND>
<CIK> 0000752743
<NAME> T. ROWE PRICE REALTY INCOME FUND I, A NO-LOAD LIMITED
PARTNE
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          SEP-30-1997
<PERIOD-START>                             OCT-01-1996
<PERIOD-END>                               JUN-30-1997
<CASH>                                       5,773,000
<SECURITIES>                                         0
<RECEIVABLES>                                   79,000
<ALLOWANCES>                                    22,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0<F1>
<PP&E>                                      26,872,000
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                              32,780,000
<CURRENT-LIABILITIES>                                0<F1>
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                  32,080,000<F2>
<TOTAL-LIABILITY-AND-EQUITY>                32,780,000
<SALES>                                              0
<TOTAL-REVENUES>                             4,445,000
<CGS>                                                0
<TOTAL-COSTS>                                2,925,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0<F3>
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              2,730,000
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          2,730,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 2,730,000
<EPS-PRIMARY>                                        0<F4>
<EPS-DILUTED>                                        0
<FN>
<F1>Not contained in registrant's unclassified balance sheet.
<F2>Partners' capital.
<F3>Not reported at interim.
<F4>Not applicable.  Net income per limited partnership unit is
$27.11.
</FN>
        <PAGE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>

The following schedule contains summary financial information which has
been extracted from the financial statements of GOLDEN CHIEF RESOURCES INC.
for the interim financial statements filed on Form 10-QSB for the periods
indicated.  These summary schedules are qualified in their entirety by
reference to such financial statements and the notes thereto.

</LEGEND>

<CIK> 0000752391
<NAME> GOLDEN CHIEF RESOURECES, INC.


<S>                             <C>						<C>
<PERIOD-TYPE>                   3-MOS					6-MOS
<FISCAL-YEAR-END>                          SEP-30-2000      SEP-30-2000
<PERIOD-START>                              JAN-1-2000       OCT-1-1999
<PERIOD-END>                               MAR-31-2000		MAR-31-2000
<CASH>                                           2,338		      2,338
<SECURITIES>                                         0		          0
<RECEIVABLES>                                        0		          0
<ALLOWANCES>                                         0		          0
<INVENTORY>                                          0		          0
<CURRENT-ASSETS>                                 2,338		      2,338
<PP&E>                                          51,782		     51,782
<DEPRECIATION>                                 (7,021)			(7,021)
<TOTAL-ASSETS>                                  47,099			 47,099
<CURRENT-LIABILITIES>                          154,749			154,749
<BONDS>                                              0                0
<PREFERRED-MANDATORY>                                0                0
<PREFERRED>                                          0                0
<COMMON>                                     1,156,276	  	  1,156,276
<OTHER-SE>                                 (1,263,926)	 	(1,263,926)
<TOTAL-LIABILITY-AND-EQUITY>                    47,099		     47,099
<SALES>                                          8,138		   	  8,138
<TOTAL-REVENUES>                                 8,235  		  8,235
<CGS>                                           25,200			 25,200
<TOTAL-COSTS>                                 (16,965)			(16,965)
<OTHER-EXPENSES>                               125,462			176,424
<LOSS-PROVISION>                                     0                0
<INTEREST-EXPENSE>                                   0                0
<INCOME-PRETAX>                              (142,427)		  (193,350)
<INCOME-TAX>                                         0                0
<INCOME-CONTINUING>                          (142,427)		  (193,350)
<DISCONTINUED>                                       0                0
<EXTRAORDINARY>                                      0                0
<CHANGES>                                            0                0
<NET-INCOME>                                 (142,427)		  (193,350)
<EPS-BASIC>                                     (0.00)        	 (0.00)
<EPS-DILUTED>                                   (0.00)        	 (0.00)
**EXHIBIT
      32.1**




**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350**


**AS
      ADOPTED PURSUANT TO**


**SECTION
      906 OF THE SARBANES-OXLEY ACT OF 2002**





In
      connection with the Annual Report of Lakeside Mortgage Fund, LLC (the
“Company”), on Form 10-KSB for the fiscal year ended December 31, 2007, as filed
      with the Securities and Exchange Commission on the date hereof (the “Report”),
      I, Paula M Lewis, President and Chief Executive Officer of Lakeside Financial
      Group, Inc., the Manager of the Company, certify, pursuant to 18 U.S.C. §1350,
      as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
      that:




(1)  The
      Report fully complies with the requirements of Section 13(a) or 15(d) of the
      Securities Exchange Act of 1934; and




(2)  The
      information contained in the Report fairly presents, in all material respects,
      the financial condition and result of operations of the Company.





Dated:
            April
                4, 2008
            /S/
                Paula M LewisPaula
                M Lewis,President
                & CEO of ManagerLakeside
                Financial Group, Inc.
EXHIBIT 32.2

Certification Pursuant
to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes -Oxley Act
of 2002

In
connection with the annual report of China Housing & Land Development, Inc. (the
Company), on Form 10-K for the period ended December 31, 2007 as filed with the Securities
and Exchange Commission (SEC) on the date hereof (the Report ), the undersigned officer of
the Company certifies, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:

i.       
          the Report fully complies with the requirements of Section 13(a)or 15(d) of the
          Securities Exchange Act of 1934; and

ii.       
          the information contained in the Report fairly presents, in all material
          respects, the financial condition and results of operations of the Company.

A
signed original of this written statement has been provided to the Company and will be
retained by the Company and will be furnished to the SEC or our staff upon request.

/s/ William XinWilliam Xin Chief
Financial Officer March 28, 2008

This
Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002 is not filed for purposes of Section 18 of the Securities Exchange Act
of 1934 but is instead furnished as provided by applicable rules of the Securities
Exchange Commission.

---
EXHIBIT 32.2   NETWORK EQUIPMENT TECHNOLOGIES, INC.   CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002   In connection with the Quarterly Report of Network Equipment Technologies, Inc. (the Company) on Form 10-Q for the period ended December 29, 2006, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, John F. McGrath, Jr., Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. February 6, 2007  /s/ JOHN F. MCGRATH, JR.John F. McGrath, Jr. 
Vice President and Chief Financial Officer
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2586 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2586

To extend the temporary suspension of duty on certain subassemblies for 
              measuring equipment for telecommunications.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

Mrs. Feinstein introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
To extend the temporary suspension of duty on certain subassemblies for 
              measuring equipment for telecommunications.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. CERTAIN SUBASSEMBLIES FOR MEASURING EQUIPMENT FOR 
              TELECOMMUNICATIONS.

    (a) In General.--Heading 9902.23.88 of the Harmonized Tariff 
Schedule of the United States (relating to subassemblies containing one 
or more printed circuit assemblies for instruments or apparatus for 
measuring or checking electrical quantities, such instruments or 
apparatus specially designed for telecommunications) is amended by 
striking the date in the effective period column and inserting ``12/31/
2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
Ahmed MINTON, DOC# S40558, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-5611

District Court of Appeal of Florida, Second District.

Opinion filed December 22, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Exhibit 10.41

 

AMENDMENT #3

 

To Letter of Intent for Proposed CRADA #2166

 

“Preclinical and Clinical Development of 1-Methyl [d]-Tryptophan as an Anticancer Agent”

 

The purpose of this Amendment is to change certain terms of the Letter of Intent (LOI) for the proposed Cooperative Research and Development Agreement (CRADA) entitled “Preclinical and Clinical Development of 1-Methyl [d]-Tryptophan as an Anticancer Agent.” These changes are reflected below, and except for these changes, all other provisions of the original CRADA LOI remain in full force and effect. Two originals of this Amendment are provided for execution; one is to remain with the National Cancer Institute (NCI) and the other original is to remain with the Collaborator.

 

Upon final signature, the term of the CRADA Letter of Intent is extended for six months from November 23, 2008 to May 23, 2009.

 

 

	
ACCEPTED AND AGREED TO:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
For the National Cancer Institute:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/Anna D. Barker
    	
 
    	
03/16/09
    	
 
    
	
Anna D. Barker, Ph.D.
    	
 
    	
Date
    
	
Deputy Director, NCI
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
For NewLink Genetics Corporation:
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
/s/Nicholas Vahanian
    	
 
    	
03/24/09
    	
 
    
	
Name: Nicholas Vahanian
    	
 
    	
Date
    
	
Title: COO
    	
 
    	
 
    


 

1
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BROOKTROUT,
INC.'S CONDENSED CONSOLIDATED BALANCE SHEET AND STATEMENTS OF INCOME FOR THE
PERIOD ENDED JUNE 30, 1999 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
BROOKTROUT, INC.'S 10-Q FOR THE PERIOD ENDED JUNE 30, 1999.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                           9,772
<SECURITIES>                                     5,040
<RECEIVABLES>                                   17,741
<ALLOWANCES>                                     2,357
<INVENTORY>                                     10,594
<CURRENT-ASSETS>                                47,963
<PP&E>                                          16,609
<DEPRECIATION>                                   7,773
<TOTAL-ASSETS>                                  76,489
<CURRENT-LIABILITIES>                           22,977
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           110
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                    76,489
<SALES>                                         33,791
<TOTAL-REVENUES>                                33,791
<CGS>                                           13,213
<TOTAL-COSTS>                                   13,213
<OTHER-EXPENSES>                                19,907
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                    787
<INCOME-TAX>                                       896
<INCOME-CONTINUING>                              (109)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (109)
<EPS-BASIC>                                      (.01)
<EPS-DILUTED>                                    (.01)


</TABLE>
IN RE: Bryan F. GILL, Jr.

NO. 2018-B-0099

Supreme Court of Louisiana.

April 6, 2018

ATTORNEY DISCIPLINARY PROCEEDING

PER CURIAM

The Office of Disciplinary Counsel ("ODC") commenced an investigation into allegations that respondent commingled personal funds with client funds in his trust account and converted client and third-party funds. Prior to the filing of formal charges, respondent and the ODC submitted a joint petition for consent discipline. Having reviewed the petition,

IT IS ORDERED that the Petition for Consent Discipline be accepted and that Bryan F. Gill, Jr., Louisiana Bar Roll number 17600, be suspended from the practice of law for a period of eighteen months. It is further ordered that nine months of the suspension shall be deferred. Following completion of the active portion of the suspension, respondent shall successfully complete a two-year period of unsupervised probation governed by the conditions set forth in the petition for consent discipline. The probationary period shall commence from the date respondent and the ODC execute a formal probation plan. Any failure of respondent to comply with the conditions of probation, or any misconduct during the probationary period, may be grounds for making the deferred portion of the suspension executory, or imposing additional discipline, as appropriate.

*276IT IS FURTHER ORDERED that all costs and expenses in the matter are assessed against respondent in accordance with Supreme Court Rule XIX, § 10.1, with legal interest to commence thirty days from the date of finality of this court's judgment until paid.
Exhibit 32.1
 CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C.
§ 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
    Date: June 8, 2009
    
    /s/ Robert A. Virtue

Robert A. VirtuePresident and Chief Executive Officer of Virco Mfg.
Corporation(Principal Executive Officer)I, Robert E. Dose, Vice President of Finance of Virco Mfg. Corporation (the Company), certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that to the best of my knowledge:1. The Quarterly Report of the Company on Form 10-Q for the quarter ended April 30, 2009, as filed
with the Securities and Exchange Commission (the Report), fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and2. The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.Date: June 8, 2009
    
    /s/ Robert E. Dose

Robert E. DoseVice President of Finance of Virco Mfg. Corporation(Principal Financial Officer)
  End of Filing